A federal jury this week decided against CareFusion (NYSE:CFN) in a patent lawsuit filed against Sigma International General Medical Apparatus over drug pump technology.
CareFusion had accused Sigma, in a lawsuit filed in February 2010, of patent infringement with the Spectrum intravenous infusion pumps, a claim that jurors rejected.
"I did not think that we were infringing," Sigma president Roger Hungerford told Bloomberg after the trial. "We try real hard to respect all competitors’ intellectual property and if we think we might be infringing something we would design around it."
San Diego-based CareFusion was denied claims to damages for lost sales, royalties and legal fees, court filings show.
Sigma attorney Michael Bettinger argued in court that CareFusion had filed the lawsuit for "strategic purposes" in order to raise its market share of infusion pumps, Bloomberg reported.
"They don’t use the technology," Bettinger said.
The news hasn’t seemed to hurt CareFusion much The Street, however, where CFN shares were trading up 2% at $25.30 around 3 p.m. today.
Sigma and CareFusion did not return requests for comment.